MedTrace Logo

Selective Versus Nonselective Alpha-blockade Prior to Pheochromocytoma Resection - Systematic Review and Meta-analysis

NCT04557072 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1344

Last updated 2021-06-18

No results posted yet for this study

Summary

Our aim was to systematically evaluate the current data on the efficacy of pretreatment with either selective or nonselective alpha-blockade on the hemodynamic instability and morbidity during pheochromocytoma resection.

Conditions

  • Pheochromocytoma

Interventions

DRUG

Selective alpha-1-antagonist

Patients treated with selective alpha-blockade (prazosin, terazosin, doxazosin)

DRUG

Non-selective alpha-1-antagonist

Patients treated with non-selective alpha-blockade (phenoxybenzamine)

Sponsors & Collaborators

  • Jagiellonian University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2020-09-01
Completion
2020-11-02

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04557072 on ClinicalTrials.gov